UBS lowered the firm’s price target on Dentsply Sirona (XRAY) to $17 from $18 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona price target lowered to $14 from $16 at Mizuho
- Dentsply Sirona Earnings Call Balances Progress and Pain
- Hold Rating Maintained as Profitability Pressures Offset In‑Line Earnings and Long‑Term Targets
- Hold Rating Reaffirmed as FX-Driven Revenue Beat Offsets EPS Miss Amid Uneven ‘Return to Growth’ Path
- Dentsply Sirona signs distribution agreement with Atlanta Dental Supply